Cargando…
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
One-year survival rates for newly diagnosed hepatocellular carcinoma (HCC) are <50%, and unresectable HCC carries a dismal prognosis owing to its aggressiveness and the undruggable nature of its main genetic drivers. By screening a custom library of shRNAs directed toward known drug targets in a...
Autores principales: | Huang, Chun-Hao, Lujambio, Amaia, Zuber, Johannes, Tschaharganeh, Darjus F., Doran, Michael G., Evans, Michael J., Kitzing, Thomas, Zhu, Nan, de Stanchina, Elisa, Sawyers, Charles L., Armstrong, Scott A., Lewis, Jason S., Sherr, Charles J., Lowe, Scott W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197965/ https://www.ncbi.nlm.nih.gov/pubmed/25128497 http://dx.doi.org/10.1101/gad.244368.114 |
Ejemplares similares
-
Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging
por: Wall, Matthew A., et al.
Publicado: (2017) -
A Pipeline for Drug Target Identification and Validation
por: Manchado, Eusebio, et al.
Publicado: (2017) -
Annotating MYC oncogene status with (89)Zr-transferrin imaging
por: Holland, Jason P., et al.
Publicado: (2012) -
De novo
MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition
por: Tarrado‐Castellarnau, Míriam, et al.
Publicado: (2017) -
Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)